Trial intelligence / Profile preview

Antibiotic Prophylaxis in Laparoscopic Cholecystectomy

NCT01888822Phase 4Terminated

Sponsor
Sapienza University of Rome
Start
Jun 2013
Primary completion
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in cholelithiasis comparing Placebo, Ampicillin-sulbactam and Ciprofloxacin (3 arms). Primary endpoint: Surgical site infection at 30 days. Started Jun 2013; status: terminated.

02

Drugs

ciprofloxacinampicillin + sulbactam
03

Conditions

cholelithiasis

Beyond the preview

Go deeper on NCT01888822.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01888822.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call